Mira Pharmaceuticals Q3 EPS $(1.18) Misses $(0.08) Estimate

Mira Pharmaceuticals (NASDAQ:MIRA) reported quarterly losses of $(1.18) per share which missed the analyst consensus estimate of $(0.08) by 1375 percent. This is a 742.86 percent decrease over losses of $(0.14) per share from the same period last year.